PronoKal Foundation

PronoKal Group is a multinational healthcare company specializing in medically supervised weight loss treatments based on a Very Low-Calorie Ketogenic Diet (VLCKD). The company's flagship offering, the PronoKal Method, integrates nutritional intervention, physical activity coaching, and behavioral support to achieve rapid and sustainable weight loss while preserving muscle mass. PronoKal operates primarily through a network of prescribing physicians and health professionals, ensuring clinical safety and efficacy for patients with obesity and related metabolic disorders. In 2022, the company was acquired by Nestlé Health Science, further integrating its medical nutrition solutions into a global health portfolio.